Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.

Katiyar P, Ma Y, Riegel A, Fan S, Rosen EM.

Mol Endocrinol. 2009 Aug;23(8):1135-46. doi: 10.1210/me.2008-0347. Epub 2009 Apr 23.

2.

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Ma Y, Katiyar P, Jones LP, Fan S, Zhang Y, Furth PA, Rosen EM.

Mol Endocrinol. 2006 Jan;20(1):14-34. Epub 2005 Aug 18.

3.

Progesterone receptor directly inhibits β-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.

Buser AC, Obr AE, Kabotyanski EB, Grimm SL, Rosen JM, Edwards DP.

Mol Endocrinol. 2011 Jun;25(6):955-68. doi: 10.1210/me.2011-0064. Epub 2011 Apr 28.

4.

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.

Wargon V, Riggio M, Giulianelli S, Sequeira GR, Rojas P, May M, Polo ML, Gorostiaga MA, Jacobsen B, Molinolo A, Novaro V, Lanari C.

Int J Cancer. 2015 Jun 1;136(11):2680-92. doi: 10.1002/ijc.29304. Epub 2014 Nov 12.

PMID:
25363551
5.

Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.

De Amicis F, Zupo S, Panno ML, Malivindi R, Giordano F, Barone I, Mauro L, Fuqua SA, Andò S.

Mol Endocrinol. 2009 Apr;23(4):454-65. doi: 10.1210/me.2008-0267. Epub 2009 Jan 15.

7.

Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.

Faivre EJ, Daniel AR, Hillard CJ, Lange CA.

Mol Endocrinol. 2008 Apr;22(4):823-37. doi: 10.1210/me.2007-0437. Epub 2008 Jan 17.

8.

BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.

Calvo V, Beato M.

Cancer Res. 2011 May 1;71(9):3422-31. doi: 10.1158/0008-5472.CAN-10-3670. Erratum in: Cancer Res. 2011 Jun 15;71(12):4325.

9.

Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity.

Arnett-Mansfield RL, Graham JD, Hanson AR, Mote PA, Gompel A, Scurr LL, Gava N, de Fazio A, Clarke CL.

Mol Endocrinol. 2007 Jan;21(1):14-29. Epub 2006 Oct 4.

PMID:
17021053
10.

p54nrb is a transcriptional corepressor of the progesterone receptor that modulates transcription of the labor-associated gene, connexin 43 (Gja1).

Dong X, Yu C, Shynlova O, Challis JR, Rennie PS, Lye SJ.

Mol Endocrinol. 2009 Aug;23(8):1147-60. doi: 10.1210/me.2008-0357. Epub 2009 May 7.

PMID:
19423654
11.
13.
14.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

15.
16.

Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.

Yudt MR, Russo LA, Berrodin TJ, Jelinsky SA, Ellis D, Cohen JC, Cooch N, Haglund E, Unwalla RJ, Fensome A, Wrobel J, Zhang Z, Nagpal S, Winneker RC.

Biochem Pharmacol. 2011 Dec 1;82(11):1709-19. doi: 10.1016/j.bcp.2011.08.006. Epub 2011 Aug 11.

PMID:
21854761
17.
18.

c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.

Chen Y, Xu J, Borowicz S, Collins C, Huo D, Olopade OI.

BMC Cancer. 2011 Jun 13;11:246. doi: 10.1186/1471-2407-11-246.

20.

Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.

Diep CH, Charles NJ, Gilks CB, Kalloger SE, Argenta PA, Lange CA.

Cell Cycle. 2013 May 1;12(9):1433-49. doi: 10.4161/cc.24550. Epub 2013 Apr 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk